{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:48:26Z","timestamp":1791478106225,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002641","name":"Konkuk University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002641","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2022-00165439"],"award-info":[{"award-number":["RS-2022-00165439"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neuropharm.2025.110700","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:15:32Z","timestamp":1758903332000},"page":"110700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["AMPK activation mitigates \u03b1-synuclein pathology and dopaminergic degeneration in cellular and mouse models of Parkinson's disease"],"prefix":"10.1016","volume":"281","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0926-3874","authenticated-orcid":false,"given":"Yoonha","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Sam","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumin","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seobin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7517-7064","authenticated-orcid":false,"given":"Hyungkeun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0242-9612","authenticated-orcid":false,"given":"Yoon Kyung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6545-8387","authenticated-orcid":false,"given":"Dong-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110700_bib1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/15548627.2016.1256932","article-title":"Autophagy and KRT8\/keratin 8 protect degeneration of retinal pigment epithelium under oxidative stress","volume":"13","author":"Baek","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2025.110700_bib2","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1080\/15548627.2021.1897962","article-title":"KRT8 (keratin 8) attenuates necrotic cell death by facilitating mitochondrial fission-mediated mitophagy through interaction with PLEC (plectin)","volume":"17","author":"Baek","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2025.110700_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110700_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2011.10.057","article-title":"Neurotoxin-based models of Parkinson's disease","volume":"211","author":"Bov\u00e9","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110700_bib5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2025.110700_bib6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bbabio.2013.10.004","article-title":"Structures of mitochondrial oxidative phosphorylation supercomplexes and mechanisms for their stabilisation","volume":"1837","author":"Chaban","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2025.110700_bib7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41419-018-0722-7","article-title":"Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T alpha-synuclein model of Parkinson's disease","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110700_bib8","first-page":"9","article-title":"Application of single-cell sequencing technology and its clinical implications in Parkinson's disease and Alzheimer's disease: a narrative review","volume":"2","author":"Chen","year":"2025","journal-title":"Adv Technol Neurosci"},{"key":"10.1016\/j.neuropharm.2025.110700_bib9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00018-024-05419-5","article-title":"Lysosomal dysfunction in alpha-synuclein pathology: molecular mechanisms and therapeutic strategies","volume":"81","author":"Dai","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"342","key":"10.1016\/j.neuropharm.2025.110700_bib10","doi-asserted-by":"crossref","first-page":"ra378","DOI":"10.1126\/scitranslmed.aaf3634","article-title":"\u03b1-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease","volume":"8","author":"Di Maio","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2025.110700_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","article-title":"Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions","volume":"8","author":"Dong-Chen","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuropharm.2025.110700_bib12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jmb.2019.06.031","article-title":"Quality control in neurons: mitophagy and other selective autophagy mechanisms","volume":"432","author":"Evans","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2025.110700_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13024-020-00367-7","article-title":"PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson's disease","volume":"15","author":"Ge","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2025.110700_bib14","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4161\/auto.6.7.13286","article-title":"The PINK1\/Parkin-mediated mitophagy is compromised by PD-associated mutations","volume":"6","author":"Geisler","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2025.110700_bib16","doi-asserted-by":"crossref","first-page":"E2634","DOI":"10.1073\/pnas.1713849115","article-title":"Identification of a highly neurotoxic alpha-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease","volume":"115","author":"Grassi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110700_bib15","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.3390\/ijms19103238","article-title":"AMPK: an epigenetic landscape modulator","volume":"19","author":"Gongol","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110700_bib17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nbd.2018.11.015","article-title":"P\u03b1-syn\u2217 mitotoxicity is linked to MAPK activation and involves tau phosphorylation and aggregation at the mitochondria","volume":"124","author":"Grassi","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2025.110700_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pneurobio.2018.09.003","article-title":"New insights into the complex role of mitochondria in Parkinson's disease","volume":"177","author":"Grunewald","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110700_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41419-021-03952-w","article-title":"Nrf2 activation induces mitophagy and reverses Parkin\/Pink1 knock down-mediated neuronal and muscle degeneration phenotypes","volume":"12","author":"Gumeni","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2025.110700_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2025.110700_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/1440-1681.12344","article-title":"\u03b2-asarone and levodopa co-administration protects against 6-hydroxydopamine-induced damage in parkinsonian rat mesencephalon by regulating autophagy: down-expression Beclin-1 and light chain 3B and up-expression P62","volume":"42","author":"Huang","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110700_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2025.110700_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuropharm.2025.110700_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/emboj.2012.300","article-title":"OXPHOS mutations and neurodegeneration","volume":"32","author":"Koopman","year":"2013","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110700_bib25","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0962-8924(00)01852-3","article-title":"Aggresomes, inclusion bodies and protein aggregation","volume":"10","author":"Kopito","year":"2000","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.neuropharm.2025.110700_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063862","article-title":"Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling","volume":"8","author":"Korecka","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110700_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cmet.2013.03.002","article-title":"Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure","volume":"17","author":"Liesa","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuropharm.2025.110700_bib28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12929-023-00975-7","article-title":"Crosstalk between mitochondrial biogenesis and mitophagy to maintain mitochondrial homeostasis","volume":"30","author":"Liu","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neuropharm.2025.110700_bib29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.neuron.2008.10.010","article-title":"Mitochondria in neuroplasticity and neurological disorders","volume":"60","author":"Mattson","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110700_bib30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.molmed.2023.03.008","article-title":"AMPK is mitochondrial medicine for neuromuscular disorders","volume":"29","author":"Mikhail","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuropharm.2025.110700_bib31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuron.2017.09.055","article-title":"Mitostasis in neurons: maintaining mitochondria in an extended cellular architecture","volume":"96","author":"Misgeld","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110700_bib32","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1089\/ars.2012.5116","article-title":"The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice","volume":"20","author":"Mo","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.neuropharm.2025.110700_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-017-0154-3","article-title":"Therapeutic potential of autophagy-enhancing agents in Parkinson's disease","volume":"12","author":"Moors","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2025.110700_bib34","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.3390\/cells9112399","article-title":"The emerging role of the lysosome in Parkinson\u2019s disease","volume":"9","author":"Navarro-Romero","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2025.110700_bib35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.brainresbull.2019.01.001","article-title":"Endoplasmic reticulum stress induced autophagy in 6-OHDA-induced Parkinsonian rats","volume":"146","author":"Ning","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2025.110700_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111216","article-title":"Regulation and roles of mitophagy at synapses","volume":"187","author":"Palikaras","year":"2020","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.neuropharm.2025.110700_bib37","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature14300","article-title":"Coordination of mitophagy and mitochondrial biogenesis during ageing in C. elegans","volume":"521","author":"Palikaras","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110700_bib38","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1080\/15548627.2021.1898748","article-title":"AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3","volume":"17","author":"Paquette","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2025.110700_bib39","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1038\/s41467-023-38401-z","article-title":"Redefining the role of AMPK in autophagy and the energy stress response","volume":"14","author":"Park","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110700_bib40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12929-023-00961-z","article-title":"Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1\/MAPK\/AMPK\/mTOR signaling pathways","volume":"30","author":"Park","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neuropharm.2025.110700_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13041-017-0340-9","article-title":"Oxidative stress and cellular pathologies in Parkinson's disease","volume":"10","author":"Puspita","year":"2017","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2025.110700_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.108963","article-title":"Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson's disease model","volume":"207","author":"Qiu","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110700_bib43","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.arr.2011.12.005","article-title":"AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network","volume":"11","author":"Salminen","year":"2012","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2025.110700_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1515\/revneuro-2012-0071","article-title":"The role of Ser129 phosphorylation of alpha-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models","volume":"24","author":"Sato","year":"2013","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110700_bib45","doi-asserted-by":"crossref","DOI":"10.1042\/NS20200008","article-title":"Mechanisms and roles of mitochondrial localisation and dynamics in neuronal function","volume":"4","author":"Seager","year":"2020","journal-title":"Neuronal Signal"},{"key":"10.1016\/j.neuropharm.2025.110700_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrn3156","article-title":"Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration","volume":"13","author":"Sheng","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110700_bib47","article-title":"Differentiation of the SH-SY5Y human neuroblastoma cell line","volume":"53193","author":"Shipley","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuropharm.2025.110700_bib48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of Parkinson's disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2025.110700_bib49","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/nprot.2017.060","article-title":"A fluorescence-based imaging method to measure in vitro and in vivo mitophagy using mt-Keima","volume":"12","author":"Sun","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2025.110700_bib50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41420-021-00676-w","article-title":"Phosphorylated \u03b1-synuclein aggregated in Schwann cells exacerbates peripheral neuroinflammation and nerve dysfunction in Parkinson's disease through TLR2\/NF-\u03baB pathway","volume":"7","author":"Sun","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.neuropharm.2025.110700_bib51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s40478-020-01101-6","article-title":"Mitochondrial defects in the respiratory complex I contribute to impaired translational initiation via ROS and energy homeostasis in SMA motor neurons","volume":"8","author":"Thelen","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.neuropharm.2025.110700_bib52","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1042\/EBC20170104","article-title":"Mitochondrial dynamics: overview of molecular mechanisms","volume":"62","author":"Tilokani","year":"2018","journal-title":"Essays Biochem."},{"issue":"18","key":"10.1016\/j.neuropharm.2025.110700_bib53","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1016\/j.molcel.2021.08.015","article-title":"AMPK: restoring metabolic homeostasis over space and time","volume":"81","author":"Trefts","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2025.110700_bib54","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1080\/15548627.2018.1493043","article-title":"6-Hydroxydopamine induces secretion of PARK7\/DJ-1 via autophagy-based unconventional secretory pathway","volume":"14","author":"Urano","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2025.110700_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101729","article-title":"A multi-faceted genotoxic network of alpha-synuclein in the nucleus and mitochondria of dopaminergic neurons in Parkinson's disease: emerging concepts and challenges","volume":"185","author":"Vasquez","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110700_bib56","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","article-title":"The mitophagy pathway and its implications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuropharm.2025.110700_bib57","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-017-0149-0","article-title":"The SH-SY5Y cell line in Parkinson's disease research: a systematic review","volume":"12","author":"Xicoy","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2025.110700_bib58","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41531-022-00361-4","article-title":"Harmol promotes \u03b1-synuclein degradation and improves motor impairment in Parkinson's models via regulating autophagy-lysosome pathway","volume":"8","author":"Xu","year":"2022","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.neuropharm.2025.110700_bib59","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","article-title":"Mitochondrial dysfunction: mechanisms and advances in therapy","volume":"9","author":"Zong","year":"2024","journal-title":"Sig Transduct Target Ther."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825004083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825004083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:02:49Z","timestamp":1773129769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825004083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":59,"alternative-id":["S0028390825004083"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110700","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AMPK activation mitigates \u03b1-synuclein pathology and dopaminergic degeneration in cellular and mouse models of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110700","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110700"}}